Rede D'Or São Luiz S.A. (RDOR3)
Sao Paulo Exchange · Brazil · prices in BRL · close of 16 Oct 2026
Key indicators
| Last close | BRL 42.57 |
|---|---|
| 52-week range | 32.27 – 48.41 |
| Return, 1 month / 3 months | +14.2% / +18.7% |
| Return, 1 year / 3 years | +15.3% / +110.7% |
| Trend | Uptrend |
| RSI (14) | 61 |
| Volatility (1 year) | 36.3% |
| Worst drawdown (1 year) | -28.3% |
| Average daily value traded | 296.22M BRL |
| Dividend yield | 9.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Rede D'Or São Luiz is a Brazilian healthcare company that operates a network of private hospitals and provides medical services to patients across the country. Its hospitals offer a broad range of care, including emergency treatment, surgery, diagnostic services and intensive care, serving patients with private health insurance as well as those who pay directly. The company is based in Rio de Janeiro and runs its hospitals under the Rede D'Or and São Luiz names.
Rede D'Or São Luiz S.A. trades under the code RDOR3 on the Sao Paulo Exchange in Brazil, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Rede D'Or São Luiz S.A. (RDOR3) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 42.57 on 16 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 218 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 15.3% and over the last three months it rose 18.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 64 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 13.1% | ||
| From 52-week high | -10.3% | ||
| Momentum | 64 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 18.7% | ||
| 6-month return | 9.0% | ||
| 12-month return, skipping the last month | 1.0% | ||
| Stability (higher is calmer) | 53 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 36.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -28.3% | ||
| Liquidity | 98 · Strong | Trades actively. | |
| Average daily value traded | 296.22M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | 73 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 9.5% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −7.0% |
|---|---|
| 1 month | +14.2% |
| 3 months | +18.7% |
| 6 months | +9.0% |
| 1 year | +15.3% |
| 3 years | +110.7% |
| 5 years | −23.6% |
Signals
| 50-day / 200-day average | 37.53 / 37.63 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.36 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 25 Jun 2026 | BRL 0.1834 |
| 26 Mar 2026 | BRL 0.1592 |
| 18 Dec 2025 | BRL 3.6811 |
| 23 Sep 2025 | BRL 0.2266 |
| 16 Jun 2025 | BRL 0.2039 |
| 26 Mar 2025 | BRL 0.1811 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.